ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1552556
This article is part of the Research TopicRecent Advancements in the Research Models of Infectious DiseasesView all 9 articles
Computed tomography-based radiomics prediction model for differentiating invasive pulmonary aspergillosis and pneumocystis jirovecii pneumonia
Provisionally accepted- 1Department of Organ Transplantation, Qilu Hospital, Cheeloo College of Medicine, Jinan, China
- 2Department of Anesthesiology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, Qingdao, China
- 3Department of Medical Oncology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, China
- 4Department of Oncology, Qilu Hospital of Shandong University, Dezhou Hospital, Dezhou, PR China., Dezhou, China
- 5Department of Radiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
- 6Scientific Research Department, Huiying Medical Technology Co., Ltd, Beijing, PR China, Beijing, China
- 7Department of Medical Oncology, Qilu Hospital, Shandong University, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Pneumocystis jirovecii and Aspergillus fumigatus are important pathogens that cause fungal pulmonary infections. Because the manifestations of pneumocystis jirovecii pneumonia (PJP) or invasive pulmonary aspergillosis (IPA) are difficult to differentiate on computed tomography (CT) images and the treatment of the two diseases is different, correct imaging diagnosis is highly significant. The present study developed and validated the diagnostic performance of a CT-based radiomics prediction model for differentiating IPA from PJP.Methods: Ninety-seven patients, 51 with IPA and 46 with PJP, were included in this study. Each patient underwent a non-enhanced chest CT examination. All patients were randomly divided into two cohorts, training and validation, at a ratio of 7:3 using random seeds automatically generated using the Radcloud platform. Image segmentation, feature extraction, and radiomic feature selection were performed on the Radcloud platform. The regions of interest (ROI) were manually segmented, including the consolidation area with the surrounding ground-glass opacities(GGO) area and the consolidation area alone. Six supervised-learning classifiers were used to develop a CT-based radiomics prediction model, which was estimated using the receiver operating characteristic (ROC) curve, area under the curve (AUC), sensitivity, specificity, precision, and f1-score. The radiomics score was also calculated to compare the prediction performance.Results: Classifiers trained with the consolidation area and surrounding GGO area as the ROI showed better prediction efficacy than classifiers trained using only the consolidation area as the ROI. The XGBoost model performed better than the other classifiers and radiomics scores in the validation cohort, with an AUC of 0.808 (95%CI, 0.655-0.961).Conclusions:This radiomics model can effectively assist in the differential diagnosis of PJP and IPA. The consolidation area with surrounding GGO was more suitable for ROI segmentation.
Keywords: Invasive pulmonary Aspergillosis1, Pneumocystis jirovecii pneumonia2, Discriminant model3, radiomics4, CT5
Received: 28 Dec 2024; Accepted: 09 May 2025.
Copyright: © 2025 Peng, Gao, He, XinYue, Wang, Dai, Yu, Sun, Tian and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Hu, Department of Medical Oncology, Qilu Hospital, Shandong University, Jinan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.